Patents by Inventor Sean E. Doyle

Sean E. Doyle has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Combination of TIM-4 antagonist and PD-1 antagonist and methods of use
    Patent number: 12227575
    Abstract: Provided are methods and compositions for treating cancer using an effective amount of a PD-1 antagonist (e.g., an antibody) in combination with a TIM-4 antagonist (e.g., an antibody).
    Type: Grant
    Filed: March 14, 2022
    Date of Patent: February 18, 2025
    Assignee: Bristol-Myers Squibb Company
    Inventors: Sean E. Doyle, Mark J. Selby, Eric Chadwick
  • Combination of TIM-4 antagonist and PD-1 antagonist and methods of use
    Patent number: 11306143
    Abstract: Provided are methods and compositions for treating cancer using an effective amount of a PD-1 antagonist (e.g., an antibody) in combination with a TIM-4 antagonist (e.g., an antibody).
    Type: Grant
    Filed: July 5, 2017
    Date of Patent: April 19, 2022
    Assignee: BRISTOL-MYERS SQUIBB COMPANY
    Inventors: Sean E. Doyle, Mark J. Selby, Eric Chadwick